This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignee: Gendiag.exe, S.l.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Roberto Elosua
Introduction
Roberto Elosua is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of thromboembolic diseases. His innovative approach combines genetic analysis with traditional risk factors to enhance patient care.
Latest Patents
Roberto holds a patent for a method related to thromboembolic disease markers. This invention focuses on a more accurate risk assessment for thromboembolic events by analyzing the presence of various genetic variants. The method also integrates conventional risk factors with the presence or absence of polymorphic markers in a subject's sample. This innovative approach aims to improve the determination of thromboembolism risk, utilizing computer-implemented means for effective implementation.
Career Highlights
Roberto Elosua has established himself as a key figure in the medical research community. His work at Gendiag.exe, S.L. has been instrumental in advancing diagnostic methods for thromboembolic diseases. His dedication to research and innovation has led to the development of groundbreaking techniques that benefit both healthcare professionals and patients.
Collaborations
Roberto collaborates with esteemed colleagues such as José Manuel Soria and Joan Vila. Their combined expertise fosters a dynamic research environment that encourages innovation and the development of new medical technologies.
Conclusion
Roberto Elosua's contributions to the field of thromboembolic disease diagnostics exemplify the impact of innovative thinking in medicine. His patent and collaborative efforts continue to pave the way for advancements that enhance patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile